Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
09/2010
09/08/2010EP2225279A1 Bivalent, bispecific antibodies
09/08/2010EP2225272A2 Novel peptides derived from ncam (fgls)
09/08/2010CN1920015B Recombination tyrosine kinase expressed in pichia yeast organelle, gene, derivative fusion albumen and preparation method thereof
09/08/2010CN1919874B Antibody molecule ATF-Fc fusion albumen of antiurokinase type fibrinolysin activator receptor and use thereof
09/08/2010CN1908015B Stabilized small molecule polypeptide capable of inhibiting HER2 high expression tumour cell proliferation
09/08/2010CN1833032B Improved method of amplifying ATP and use thereof
09/08/2010CN1566342B Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same
09/08/2010CN101824091A G-CSF (Granulocyte-Colony Stimulating Factor) fusion protein mutant, preparation method and application thereof
09/08/2010CN101824083A C-terminal deletion type p43 protein and application thereof in medicaments for treating tumor
09/08/2010CN101824072A Short peptide for inhibiting growth of solid tumor and leukemia cancer cells and application thereof
09/08/2010CN101475641B Adenovirus vector avian influenza recombinant vaccine
09/08/2010CN101182355B Antibacterial peptide citropin 1.18 fusion protein
09/08/2010CN101113179B Human antibody sample molecule TEM8-Fc based on tumour endocytosis sign 8 and its application in tumour treatment
09/07/2010US7790870 nucleic acid molecule encoding a fusion protein comprising four linked polypeptides; suitable for use in gene therapeutical treatment of patients infected with HIV
09/07/2010US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders
09/07/2010US7790850 comprising a fusion protein comprising a first portion of a GPCR, where the first portion comprises the TM1, TM2, TM3, TM4 and TM5 regions of the GPCR, a stable folded protein insertion and a second portion of the GPCR, where the second portion comprises the TM6 and TM7 regions
09/07/2010US7790848 g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; for screening tastants
09/07/2010US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT
09/07/2010US7790415 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents
09/02/2010WO2010099019A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/02/2010WO2010097709A2 Polypeptides for the prevention or treatment of malaria
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010CA2753438A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/01/2010EP2224007A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof
09/01/2010EP2224006A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
09/01/2010EP2224001A1 Improved epitope displaying phage
09/01/2010EP2223937A1 Polypeptides for the prevention or treatment of malaria
09/01/2010EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/01/2010EP2222710A1 Recombinant rsv antigens
09/01/2010EP1207905B1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
09/01/2010CN1995065B Fusion protein for suppressing PTTG expression and its coding gene and uses
09/01/2010CN101819201A Polypeptide composition for detecting immune antibody of rheumatoid arthritis in vitro
09/01/2010CN101818162A Molecular design of IBDV (Infectious Bursal Disease Virus) antigen epitope and HBcAg (Hepatitis B Core Antigen) chimeric gene
09/01/2010CN101817883A Housefly cecropin-human lysozyme fusion protein, and preparation method and application thereof
08/2010
08/31/2010US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents
08/31/2010US7786263 Human T1R2 taste receptor polypeptides
08/31/2010US7786257 Lymphocyte receptors peptide for use as tool in prevention and treatment of infection, autoimmune and cell proliferative disorders; mimetics
08/31/2010US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785802 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste
08/31/2010US7785599 Albumin fusion proteins
08/31/2010CA2290886C Nucleic acid binding proteins
08/31/2010CA2217871C Altered polypeptides with increased half-life
08/31/2010CA2190371C Receptor for oncostatin m
08/26/2010WO2010095881A2 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof
08/26/2010WO2010095455A1 Hypo-immunogenic streptavidin and use thereof
08/26/2010WO2010077672A3 Control of mosquito larvae with bti toxins and tmof
08/26/2010WO2010002478A4 Glycopeptide and uses thereof
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
08/26/2010US20100215693 Immunological herpes simplex virus antigens and methods for use thereof
08/26/2010US20100215681 Fusion proteins comprising hiv-1 tat and/or nef proteins
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010CA2767752A1 Improved anti-serum albumin binding variants
08/26/2010CA2753181A1 Target-activated cell/tissue penetrating peptide for delivery of impermeable compounds and use thereof
08/26/2010CA2753099A1 Modifications of cupredoxin derived peptides and methods of use thereof
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/25/2010EP2221314A1 A soluble tumor necrosis factor receptor mutant
08/25/2010EP2220125A2 Production of fc-fusion polypeptides in eukaryotic algae
08/25/2010CN1970574B Double function infusion protein for thrombolysis and anticoagulation , its preparation method and uses
08/25/2010CN101812474A Preparation method and application of osteoporotegerin-heat-shock protein 65-fused protein
08/25/2010CN101812135A Fusion protein with high-efficient platelet-increasing role and preparation method thereof
08/25/2010CN101812134A Antibodies that bind cell-associated ca 125/0722p and methods of use thereof
08/25/2010CN101812118A Specific binding agents of human angiopoietin-2
08/24/2010US7781188 Nucleotide and protein sequences of Nogo genes and methods based thereon
08/24/2010US7781181 Human T1R2 polypeptide functional assays
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/19/2010WO2010092963A1 Drug transporter, and adjuvant and vaccine each utilizing same
08/19/2010WO2010070453A3 Meningococcal vaccines including hemoglobin receptor
08/19/2010WO2010051533A3 Compositions of engineered human arginases and methods for treating cancer
08/19/2010WO2010048530A3 Methods and compositions employing an iip45 targeting ligand
08/19/2010WO2010025421A3 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209444 MAGE3 Polypeptides
08/19/2010US20100209440 Targeted Delivery of siRNA
08/18/2010EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
08/18/2010CN101809152A Fluorescent protein with deep blue color
08/18/2010CN101809029A Peptide capable of extending half-life of peptide of interest in plasma
08/18/2010CN101805408A Antitumor and thrombolytic double-effect chimeric protein, preparation method thereof and use thereof
08/17/2010US7777003 Receptor polypeptides deficient in B cell epitope, in which two or more T cell epitopes are fused; immunomodulator without side effects
08/17/2010US7776562 Reversible MHC multimer staining for functional purification of antigen-specific T cells
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/12/2010WO2010091441A2 Stable, functional chimeric cellobiohydrolases
08/12/2010WO2010090873A2 Polypeptides and their use as adjuvants
08/12/2010WO2010019257A3 Prodrug activation in cancer cells using molecular switches
08/12/2010US20100204458 Process for the Production of Immunogenic Compositions
08/12/2010US20100204129 Use of a peptide as a therapeutic agent
08/12/2010US20100203042 Recombinant anti-vla4 antibody molecules
08/12/2010US20100203011 Mammalian Cytokines; Related Reagents and Methods
08/12/2010US20100202962 Cripto blocking antibodies and uses thereof
08/12/2010CA2751762A1 Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof
08/12/2010CA2749965A1 Methods and compositions for treating neuropathies
08/12/2010CA2748314A1 Extended recombinant polypeptides and compositions comprising same
08/11/2010EP2216409A1 Albumin fusion proteins
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 295